PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97744432 |
Filing Date: 01/06/2023 |
Input Field |
Entered |
SERIAL NUMBER | 97744432 |
---|---|
MARK INFORMATION | |
*MARK | CORE |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | CORE |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Predictive Oncology Inc. |
INTERNAL ADDRESS | Suite 900 |
*MAILING ADDRESS | 2915 Commers Drive |
*CITY | Eagan |
*STATE (Required for U.S. applicants) |
Minnesota |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
55121 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Medical research; scientific research, namely, providing data analytics and data modelling to others in the fields of medical and pharmaceutical research and development, using artificial intelligence for data analytics and data modelling in the fields of medical and pharmaceutical research and development |
FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 12/05/2022 |
FIRST USE IN COMMERCE DATE | At least as early as 01/03/2023 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPE0-50220181218-20230106 085325777052_._CORE_scree nshots.pdf |
CONVERTED PDF FILE(S) (2 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\977\444\97744432\xml1\ APP0003.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\977\444\97744432\xml1\ APP0004.JPG | |
SPECIMEN DESCRIPTION | Screen shots from Registrant's web page |
WEBPAGE URL | www.predictive-oncology.com |
WEBPAGE DATE OF ACCESS | 01/05/2023 |
ATTORNEY INFORMATION | |
NAME | Eran Kahana |
ATTORNEY DOCKET NUMBER | 2018-0538 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Maslon LLP |
INTERNAL ADDRESS | 3300 Wells Fargo Center |
STREET | 90 South 7th Street |
CITY | Minneapolis |
STATE | Minnesota |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 55402 |
PHONE | 612-672-8385 |
FAX | 6126428400 |
EMAIL ADDRESS | Eran.Kahana@maslon.com |
CORRESPONDENCE INFORMATION | |
NAME | Eran Kahana |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | Eran.Kahana@maslon.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | IPteam33@maslon.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /Bob Myers/ |
SIGNATORY'S NAME | Bob Myers |
SIGNATORY'S POSITION | Chief Financial Officer |
DATE SIGNED | 01/06/2023 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97744432 |
Filing Date: 01/06/2023 |
The applicant's current Correspondence Information: |
Eran Kahana |
PRIMARY EMAIL FOR CORRESPONDENCE: Eran.Kahana@maslon.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): IPteam33@maslon.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|